Immunome Inc. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2021-05-24

Reporting Person: WAGENHEIM PHILIP (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-24	Common Stock	P	13500	$18.35	Acquired	397397	Direct

Footnotes

F1: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.15 to $18.40, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

F2: Does not include (i) 166,666 shares previously reported as indirectly held by the reporting person because the reporting person is no longer trustee of the Rapoport Family Trust and (ii) 443,743 shares previously reported as held indirectly through BCM Advisory Partners LLC (the "LLC") in which the reporting person did not have a pecuniary interest and which were distributed to other members of the LLC.